Alzheimer’s disease – Giuseppe Caruso

February 2023

Effects of physical activity and exercise interventions on Alzheimer’s disease: an umbrella review of existing meta-analyses
Effects of physical activity and exercise interventions on Alzheimer’s disease: an umbrella review of existing meta-analyses

Effects of physical activity and exercise interventions on Alzheimer’s disease: an umbrella review of existing meta-analyses

Lucia Di Pietro2023-03-06T15:52:47+01:00February 1st, 2023|Neurodegenerative diseases|

López-Ortiz S, Lista S, Valenzuela PL, Pinto-Frag [...]

May 2022

Neuroprotective Effect of Carnosine Is Mediated by Insulin-Degrading Enzyme
Neuroprotective Effect of Carnosine Is Mediated by Insulin-Degrading Enzyme

Neuroprotective Effect of Carnosine Is Mediated by Insulin-Degrading Enzyme

Lucia Di Pietro2023-03-06T15:16:06+01:00May 18th, 2022|Other, Therapeutic potential of carnosine|

Distefano A, Caruso G, Oliveri V, Bellia F, Sbard [...]

December 2021

Antioxidant Activity of Fluoxetine and Vortioxetine in a Non-Transgenic Animal Model of Alzheimer’s Disease
Antioxidant Activity of Fluoxetine and Vortioxetine in a Non-Transgenic Animal Model of Alzheimer’s Disease

Antioxidant Activity of Fluoxetine and Vortioxetine in a Non-Transgenic Animal Model of Alzheimer’s Disease

Giuseppe Caruso2023-03-06T16:02:30+01:00December 24th, 2021|Other|

Caruso G, Grasso M, Fidilio A, Torrisi SA, Musso [...]

July 2021

Improving cognition with nutraceuticals targeting TGF-β1 signaling
Improving cognition with nutraceuticals targeting TGF-β1 signaling

Improving cognition with nutraceuticals targeting TGF-β1 signaling

Giuseppe Caruso2021-09-06T07:04:13+01:00July 5th, 2021|Pharmacology and diseases|

Grasso M*, Caruso G*, Godos J, Bonaccorso A, Carb [...]

April 2021

Carnosine protects macrophages against the toxicity of Aβ1-42 oligomers by decreasing oxidative stress
Carnosine protects macrophages against the toxicity of Aβ1-42 oligomers by decreasing oxidative stress

Carnosine protects macrophages against the toxicity of Aβ1-42 oligomers by decreasing oxidative stress

Giuseppe Caruso2021-09-06T05:57:45+01:00April 26th, 2021|Therapeutic potential of carnosine|

Caruso G*, Benatti C*, Musso N, Fresta CG, Fidili [...]

March 2021

The therapeutic potential of carnosine/anserine supplementation against cognitive decline: a systematic review with meta-analysis
The therapeutic potential of carnosine/anserine supplementation against cognitive decline: a systematic review with meta-analysis

The therapeutic potential of carnosine/anserine supplementation against cognitive decline: a systematic review with meta-analysis

Giuseppe Caruso2021-09-05T19:32:31+01:00March 4th, 2021|Therapeutic potential of carnosine|

Caruso G, Godos J, Castellano S, Micek A, Murabit [...]

July 2020

New antipsychotic drugs for the treatment of agitation and psychosis in Alzheimer’s disease: focus on brexpiprazole and pimavanserin
New antipsychotic drugs for the treatment of agitation and psychosis in Alzheimer’s disease: focus on brexpiprazole and pimavanserin

New antipsychotic drugs for the treatment of agitation and psychosis in Alzheimer’s disease: focus on brexpiprazole and pimavanserin

Giuseppe Caruso2021-09-05T11:55:49+01:00July 8th, 2020|Pharmacology and diseases|

Caraci F, Santagati M, Caruso G, Cannavò D, Leggio [...]

March 2020

A path towards precision medicine for neuroinflammatory mechanisms in Alzheimer’s disease
A path towards precision medicine for neuroinflammatory mechanisms in Alzheimer’s disease

A path towards precision medicine for neuroinflammatory mechanisms in Alzheimer’s disease

Giuseppe Caruso2021-09-05T12:02:59+01:00March 31st, 2020|Neurodegenerative diseases|

Hampel HJ, Caraci F, Cuello AC, Caruso G, Nisticò [...]

December 2019

β-amyloid and oxidative stress: perspectives in drug development
β-amyloid and oxidative stress: perspectives in drug development

β-amyloid and oxidative stress: perspectives in drug development

Giuseppe Caruso2021-09-05T12:06:03+01:00December 1st, 2019|Neurodegenerative diseases|

Caruso G, Spampinato SF, Cardaci V, Caraci F, Sort [...]

June 2019

Fluoxetine and vortioxetine reverse depressive-like phenotype and memory deficits induced by Aβ 1-42 oligomers in mice: a key role of transforming growth factor-β1
Fluoxetine and vortioxetine reverse depressive-like phenotype and memory deficits induced by Aβ 1-42 oligomers in mice: a key role of transforming growth factor-β1

Fluoxetine and vortioxetine reverse depressive-like phenotype and memory deficits induced by Aβ 1-42 oligomers in mice: a key role of transforming growth factor-β1

Giuseppe Caruso2021-09-05T13:10:20+01:00June 21st, 2019|Pharmacology and diseases|

Torrisi SA, Geraci F, Tropea MR, Grasso M, Caruso [...]